Effect of Eluxadoline on Abdominal and Bowel Symptoms Over Time in Phase 3 Clinical Trials in Patients With Irritable Bowel Syndrome With Diarrhea

被引：1
|
作者：
Harris, Lucinda [1 ]
Lucak, Susan [2 ]
Chang, Lin [3 ]
Dove, Leonard S. [4 ]
Covington, Paul S. [5 ]
机构：
[1] Mayo Clin, Phoenix, AZ USA
[2] Columbia Univ, Med Ctr, New York, NY USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[4] Furiex Pharmaceut, Driftwood, TX USA
[5] Clin Dynamix, Wilmington, NC USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2015年 / 110卷
关键词：
D O I：
10.14309/00000434-201510001-01761
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1761
引用
收藏
页码：S748 / S748
页数：1
相关论文
共 50 条
  • [21] Eluxadoline in irritable bowel syndrome with diarrhea: rationale, evidence and place in therapy
    Barshop, Kenneth
    Staller, Kyle
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2017, 8 (11) : 153 - 160
  • [22] Safety of Eluxadoline in Patients With Irritable Bowel Syndrome Response
    Cash, Brooks D.
    Lacy, Brian E.
    Schoenfeld, Philip S.
    Dove, Leonard S.
    Covington, Paul S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 (10): : 1617 - 1617
  • [23] Impact of Baseline Pain Severity on the Efficacy of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea
    Harris, Lucinda A.
    Lucak, Susan
    Chang, Lin
    Gutman, Catherine
    Andrae, David A.
    Dove, Leonard S.
    Covington, Paul S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S254 - S254
  • [24] Robustness of Eluxadoline for the Treatment of Irritable Bowel Syndrome With Diarrhea: Results From Phase 3 Composite Endpoint Assessments
    Lacy, Brian E.
    Dove, Scott
    Andrae, David
    Davenport, J. Michael
    Turner, Lisa
    Lopez, Rocio
    Covington, Paul S.
    GASTROENTEROLOGY, 2015, 148 (04) : S491 - S491
  • [25] Update on Eluxadoline for the Treatment of Irritable Bowel Syndrome with Diarrhea: Patient Selection and Perspectives
    Liu, Rebecca
    Staller, Kyle
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 1391 - 1400
  • [26] Effect of Linaclotide on Severe Abdominal Symptoms in Patients With Irritable Bowel Syndrome With Constipation
    Rao, Satish S. C.
    Quigley, Eamonn M. M.
    Shiff, Steven J.
    Lavins, Bernard J.
    Kurtz, Caroline B.
    MacDougall, James E.
    Currie, Mark G.
    Johnston, Jeffrey M.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (04) : 616 - 623
  • [27] Abdominal Pain Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea
    Lembo, Anthony
    Rao, Satish S. C.
    Heimanson, Zeev
    Pimentel, Mark
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2020, 11 : e00144
  • [28] Effect of esomeprazole on symptoms of patients with irritable bowel syndrome (IBS) and functional diarrhea (FD)
    Ringel, Yehuda
    Morris, Carolyn B.
    Maier, Danielle
    Hu, Yuming
    McKee, Michelle M.
    Bangdiwala, Shrikant I.
    Drossman, Douglas A.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S476 - S476
  • [29] RIFAXIMIN SIGNIFICANTLY IMPROVES BOWEL MOVEMENT URGENCY IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH DIARRHEA: A POOLED ANALYSIS OF THREE PHASE 3 TRIALS
    Schoenfeld, Philip S.
    Brenner, Darren M.
    Pichetshote, Nipaporn
    Heimanson, Zeev
    Lacy, Brian E.
    GASTROENTEROLOGY, 2021, 160 (06) : S281 - S281
  • [30] Safety and tolerability of tegaserod in patients with irritable bowel syndrome and diarrhea symptoms
    Fidelholtz, J
    Smith, W
    Rawls, J
    Shi, YQ
    Zack, A
    Rüegg, P
    Lefkowitz, M
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (05): : 1176 - 1181
12345